Related references
Note: Only part of the references are listed.Targeted delivery of nano-PTX to the brain tumor-associated macrophages
Lei Zou et al.
ONCOTARGET (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
Jane Cullis et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Macrophage depletion impairs skeletal muscle regeneration: The roles of regulatory factors for muscle regeneration
Xiaoguang Liu et al.
CELL BIOLOGY INTERNATIONAL (2017)
Poly(lactic acid)-based particulate systems are promising tools for immune modulation
Carina Peres et al.
ACTA BIOMATERIALIA (2017)
Mechanisms and Barriers in Cancer Nanomedicine: Adressing Challenges, Looking for Solutions
Thomas J. Anchordoquy et al.
ACS NANO (2017)
Trabectedin for the treatment of breast cancer
Maurizio D'Incalci et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells
Amy M. Wen et al.
BIOCONJUGATE CHEMISTRY (2016)
Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment
Xu Song et al.
BIOMATERIALS (2016)
Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases
Tomonori Tanei et al.
CANCER RESEARCH (2016)
Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions
Ryan A. Ortega et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
Hilary Shmeeda et al.
JOURNAL OF DRUG TARGETING (2016)
Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer
Mengmeng Niu et al.
MOLECULAR PHARMACEUTICS (2016)
Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant
Karin A. Binnemars-Postma et al.
NANOMEDICINE (2016)
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
Saeid Zanganeh et al.
NATURE NANOTECHNOLOGY (2016)
Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy
Jingxing Si et al.
SMALL (2016)
Depletion of Hepatic Macrophages Aggravates Liver Lesions Induced in Rats by Thioacetamide (TAA)
Hossain M. Golbar et al.
TOXICOLOGIC PATHOLOGY (2016)
Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers
Fan Zhang et al.
BIOMATERIALS (2015)
Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress
Marius Costel Alupei et al.
CANCER LETTERS (2015)
Macrophage polarization in pathology
Antonio Sica et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Targeting the STAT6 pathway to inhibit tumor-associated macrophages-induced tumor growth and metastasis in breast cancer
K. Binnemars-Postma et al.
EUROPEAN JOURNAL OF CANCER (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2015)
PET Imaging of Tumor-Associated Macrophages with Zr-89-Labeled High-Density Lipoprotein Nanoparticles
Carlos Perez-Medina et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages
Ryan A. Ortega et al.
NANOSCALE (2015)
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Miles A. Miller et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Human mononuclear phagocyte system reunited
Muzlifah Haniffa et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Balancing the innate immune system in tumor development
Catharina Hagerling et al.
TRENDS IN CELL BIOLOGY (2015)
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Miles A. Miller et al.
NATURE COMMUNICATIONS (2015)
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
Madappa Kundranda et al.
Drug Design Development and Therapy (2015)
Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
Sravan Kumar Patel et al.
THERANOSTICS (2015)
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
Jeffrey Lee Jensen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
M2 polarization enhances silica nanoparticle uptake by macrophages
Jessica Hoppstaedter et al.
FRONTIERS IN PHARMACOLOGY (2015)
Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
Jun Tang et al.
SCIENCE ADVANCES (2015)
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages
Yoshiyuki Hattori et al.
JOURNAL OF LIPOSOME RESEARCH (2015)
Emerging Applications for Ferumoxytol as a Contrast Agent in MRI
Mustafa R. Bashir et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Non-Viral Nanoparticle Delivers Small Interfering RNA to Macrophages In Vitro and In Vivo
Mei Zhang et al.
PLOS ONE (2015)
Macrophage density and macrophage colony-stimulating factor expression predict the postoperative prognosis in patients with intrahepatic cholangiocarcinoma
Kosuke Oishi et al.
SURGERY TODAY (2015)
Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer
Simon Junankar et al.
CANCER DISCOVERY (2015)
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
Li Shen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy
Xiudan Zhan et al.
BIOMATERIALS (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages
Yasutaka Okabe et al.
CELL (2014)
Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs
Parag P. Patwardhan et al.
CLINICAL CANCER RESEARCH (2014)
Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
Teresa S. Kim et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma
Kirsten Kuebler et al.
GYNECOLOGIC ONCOLOGY (2014)
EPR: Evidence and fallacy
Joseph W. Nichols et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
Xuesong Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Biodistribution and in Vivo Activities of Tumor-Associated Macrophage-Targeting Nanoparticles Incorporated with Doxorubicin
Mengmeng Niu et al.
MOLECULAR PHARMACEUTICS (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
N. Weizman et al.
ONCOGENE (2014)
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
Raffaella Sabatino et al.
PLOS ONE (2014)
Quantitative Evaluation of the Reticuloendothelial System Function with Dynamic MRI
Ting Liu et al.
PLOS ONE (2014)
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy
Marjolein Sluijter et al.
PLOS ONE (2014)
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
Zhong-Yu Yuan et al.
ONCOTARGETS AND THERAPY (2014)
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Warangkana Lohcharoenkal et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
Carlos E. Prada et al.
ACTA NEUROPATHOLOGICA (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Xiaoqiang Tang
CANCER LETTERS (2013)
ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
Yan Zhang et al.
CELL RESEARCH (2013)
Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
Janesh Pillay et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Tumour-associated macrophages and cancer
Jenny Cook et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Anti-tumour strategies aiming to target tumour-associated macrophages
Xiaoqiang Tang et al.
IMMUNOLOGY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity
Hilary Shmeeda et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
Kavitha Yaddanapudi et al.
JOURNAL OF IMMUNOLOGY (2013)
Macrophage-Specific RNA Interference Targeting via Click, Mannosylated Polymeric Micelles
Shann S. Yu et al.
MOLECULAR PHARMACEUTICS (2013)
Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified Nanoparticles
Saijie Zhu et al.
MOLECULAR PHARMACEUTICS (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Hydrazinocurcumin Encapsuled Nanoparticles Re-Educate Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression (Publication with Expression of Concern. See vol. 14, 2019)
Xiwen Zhang et al.
PLOS ONE (2013)
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Maryelise Cieslewicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression
Claudia A. Dumitru et al.
SEMINARS IN CANCER BIOLOGY (2013)
The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins?
Sven Brandau et al.
SEMINARS IN CANCER BIOLOGY (2013)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Subhra K. Biswas et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells
Debbie C. Strachan et al.
ONCOIMMUNOLOGY (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
The Cell Biology of Phagocytosis
Ronald S. Flannagan et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Differential Uptake of Chemically Modified Cowpea Mosaic Virus Nanoparticles in Macrophage Subpopulations Present in Inflammatory and Tumor Microenvironments
Arpita Agrawal et al.
BIOMACROMOLECULES (2012)
PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes
Landon W. Locke et al.
BIOMATERIALS (2012)
Tumor-associated neutrophils: friend or foe?
Zvi G. Fridlender et al.
CARCINOGENESIS (2012)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ning-Bo Hao et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
P. Allavena et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
Haitao Fan et al.
CLINICAL CANCER RESEARCH (2012)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Effect of molecular size and modification pattern on the internalization of water soluble β-(1→3)-(1→4)-glucan by primary murine macrophages
Mei Zhang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
Anders Etzerodt et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy
Zhen Huang et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
Dongchang Zhao et al.
CLINICAL CANCER RESEARCH (2011)
MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles
Heike E. Daldrup-Link et al.
CLINICAL CANCER RESEARCH (2011)
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
Moniek Heusinkveld et al.
JOURNAL OF IMMUNOLOGY (2011)
Identification and manipulation of tumor associated macrophages in human cancers
Moniek Heusinkveld et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Tumour macrophages as potential targets of bisphosphonates
Thea L. Rogers et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity
Debbie Liao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al.
CANCER RESEARCH (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
The chemokine system in cancer biology and therapy
Alberto Mantovani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
Justin P. Edwards et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas
Darya Alizadeh et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages
Wangyang Yu et al.
PHARMACEUTICAL RESEARCH (2010)
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
G-One Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of Surface Properties on Nanoparticle-Cell Interactions
Ayush Verma et al.
SMALL (2010)
Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells
Xu-Feng Qi et al.
TOXICOLOGY LETTERS (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
Taku Nagai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages
Amaya Puig-Kroeger et al.
CANCER RESEARCH (2009)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?
H. K. Brown et al.
CURRENT CANCER DRUG TARGETS (2009)
High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
Tong Ding et al.
HUMAN PATHOLOGY (2009)
Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
Dorothee Duluc et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model
Michelle VanHandel et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
Neil Desai et al.
TRANSLATIONAL ONCOLOGY (2009)
Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine:: In vitro and in vivo evaluation
Amandeep Kaur et al.
ACTA PHARMACEUTICA (2008)
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
Neil P. Desai et al.
ANTI-CANCER DRUGS (2008)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Cancer related inflammation: The macrophage connection
Antonio Sica et al.
CANCER LETTERS (2008)
Tumor versus tumor-associated macrophages: How hot is the link?
C. Guruvayoorappan
INTEGRATIVE CANCER THERAPIES (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland
Wendy V. Ingman et al.
DEVELOPMENTAL DYNAMICS (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics
Cedric Klumpp et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2006)
Signaling mechanisms, interaction partners, and target genes of STAT6
Daniel Hebenstreit et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2005)
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
P Allavena et al.
CANCER RESEARCH (2005)
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer
RV Murthy et al.
CLINICAL CANCER RESEARCH (2005)
Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation
G Raes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Macrophage depletion induced by clodronate-loaded erythrocytes
L Rossi et al.
JOURNAL OF DRUG TARGETING (2005)
Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma
MJ Turk et al.
CANCER LETTERS (2004)
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases
T Hagemann et al.
CARCINOGENESIS (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression
A Mantovani et al.
EUROPEAN JOURNAL OF CANCER (2004)
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors
J Wyckoff et al.
CANCER RESEARCH (2004)
Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice
Y Hattori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Intravital imaging of cell movement in tumours
J Condeelis et al.
NATURE REVIEWS CANCER (2003)
A critical role for stat3 signaling in immune tolerance
FD Cheng et al.
IMMUNITY (2003)
Human macrophage activation programs induced by bacterial pathogens
GJ Nau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma
M Tanaka et al.
MOLECULAR THERAPY (2002)
Tumors and inflammatory infiltrates: Friends or foes?
C Brigati et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity
ES White et al.
JOURNAL OF IMMUNOLOGY (2001)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Liposome-mediated DNA vaccination: the effect of vesicle composition
Y Perrie et al.
VACCINE (2001)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
E Erba et al.
EUROPEAN JOURNAL OF CANCER (2001)
Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
